AWP1 Antibodies

Santa Cruz Biotechnology offers a broad range of AWP1 Antibodies for investigating AWP1 protein function. Monoclonal AWP1 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AWP1, or Atypical Wnt Pathway Inhibitor 1, plays a critical role in regulating Wnt signaling pathways, which are essential for cell proliferation, differentiation, and development. Dysregulation of AWP1 has been implicated in various diseases, including cancer, making it a significant target for therapeutic research. Understanding AWP1 function can provide insights into cellular processes and potential interventions in Wnt-related pathologies. Research utilizing AWP1 monoclonal antibodies has revealed important mechanisms in cell signaling and development. Investigating AWP1's role in Wnt pathway regulation continues to yield valuable insights into disease progression and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal AWP1 antibodies enable researchers worldwide to advance scientific understanding of cellular signaling pathways and disease mechanisms.